A CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHANDANADICHURNA ANJANA ALONG WITH SHATAVARYADI CHURNA IN THE MANAGEMENT OF SHUKLA ARMA (NON- PROGRESSIVE PTERYGIUM)
*Dr. Amanveer Kour Chani, Prof. Dr. Ashu, Prof. Dr. Manoj Kumar
ABSTRACT
Shukla Arma (Non-progressive Pterygium) is one of the common ocular surface disorders described under Shuklagata Netraroga in Ayurveda. It is characterized by a slow-growing, white fibrovascular tissue extending from the conjunctiva towards the cornea. In modern ophthalmology, non-progressive pterygium is considered an atrophic fibrovascular degeneration of the conjunctiva, commonly associated with prolonged exposure to ultraviolet radiation, dust, wind, and dry climatic conditions. Although surgical excision remains the standard treatment, it is associated with a high recurrence rate and postoperative complications. Therefore, there is a need for a safe, effective, and non-surgical treatment modality. In Ayurveda, Shukla Arma can be managed by Lekhana Anjana when the lesion is small, thin, soft, and slowly progressive. Chandanadichurna Anjana, owing to its Lekhana and Kaphahara properties, along with Shatavaryadi Churna, which possesses Kaphahara, Rasayana, and Chakshushya properties, may provide an effective conservative management for Shukla Arma. Methodology: A prospective, open-label, single-arm clinical study will be conducted on 30 patients diagnosed with Shukla Arma (Non-progressive Pterygium) fulfilling the inclusion and exclusion criteria. All enrolled patients will receive Chandanadichurna Anjana (2 Shalaka once daily in the morning) along with Shatavaryadi Churna (6 g/day in divided doses with Ghrita and Madhu) for 30 days. Patients will be assessed before, during, and after treatment using subjective parameters including foreign body sensation, lacrimation, photophobia, and burning sensation, along with objective assessment of pterygium size using a Castroviejo caliper. Follow-up will be carried out on the 15th and 30th day.
[Full Text Article] [Download Certificate]

